Comprehensive bioburden testing and analysis supporting sterilisation validation, regulatory compliance, and microbiological control for medical device and pharmaceutical manufacturers.
Comprehensive bioburden testing and analysis supporting sterilisation validation, regulatory compliance, and microbiological control for medical device and pharmaceutical manufacturers.
Bioburden testing or Bioburden analysis is a microbiological test used to determine the number of viable microorganisms present on a product, component, or raw material prior to sterilisation. The purpose of bioburden analysis is to quantify microbial contamination and provide manufacturers with essential information about the microbiological quality of their products and production processes.
For manufacturers of sterile medical devices and healthcare products, bioburden analysis forms an important part of microbiological quality control. Accurate measurement of microbial load helps organisations understand contamination levels within their manufacturing process and ensures sterilisation methods are capable of consistently achieving the required sterility assurance level.
Bioburden testing plays a key role in sterilisation validation and routine process monitoring. Determining the microbial population present before sterilisation helps manufacturers establish appropriate sterilisation cycles and verify that those processes remain effective over time. Regular testing also helps identify trends or changes in microbial levels that could indicate potential issues within the manufacturing environment.
Bioburden analysis is also required to support compliance with recognised international standards such as ISO 11737. Regulatory authorities expect manufacturers to demonstrate control of microbial contamination through validated testing programmes. Reliable laboratory data from bioburden analysis helps support regulatory submissions, audits, and ongoing product quality assurance.
CLS provides bioburden testing services designed to support medical device and pharmaceutical manufacturers throughout product development, validation, and routine manufacturing. Testing is performed using validated microbiological methods that maximise microorganism recovery while maintaining accuracy and consistency in results.
The CLS microbiology laboratory works closely with clients to develop testing programmes suited to their specific products and manufacturing processes. With extensive experience in microbiological testing and regulatory standards, CLS helps organisations maintain product safety, meet compliance requirements, and ensure reliable sterilisation performance through dependable bioburden analysis.
Trusted by leading names